Canada Markets closed

MYND Life Sciences Inc. (MYNDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.07290.0000 (0.00%)
At close: 10:03AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0729
Open0.0729
BidN/A x N/A
AskN/A x N/A
Day's Range0.0729 - 0.0729
52 Week Range0.0729 - 1.1000
Volume22,000
Avg. Volume354
Market Cap4.356M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Mynd Life Sciences Terminates Proposed Transaction with Tidal Psychedelics

    Vancouver, British Columbia--(Newsfile Corp. - June 29, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("Mynd" or the "Company") announces that it has terminated the non-binding memorandum of understanding ("MOU") to acquire all the issued and outstanding shares of Tidal Care Inc. o/a Tidal Psychedelics ("Tidal") as disclosed in Mynds's March 16, 2022 press release, due to differences in the strategic direction of the proposed acquisition. Mynd has advised Tidal of ...

  • Newsfile

    MYND Life Sciences Announces Chief Scientific Officer, Dr. Wilf Jefferies, Induction as a National Academy of Inventors Fellow

    Vancouver, British Columbia--(Newsfile Corp. - June 17, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("Mynd" or the "Company"), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with relentless neurological diseases, is pleased to announce that Dr. Wilfred Jefferies, Mynd's Chief Scientific Officer, has been inducted as a Fellow of the National Academy of Inventors. Globally, the most accomplished inve

  • Baystreet

    Stocks in play: MYND Life Sciences

    Announced positive preclinical data in measuring dosing accuracy in psilocybins and psilocybin analogs. ...